Quest Diagnostics Incorporated, with its wide range of diagnostic information services, has a moderate growth potential given its comprehensive diagnostic solutions and extensive network. While its fundamental scores indicate a mix of strengths and weaknesses, the firm's consistent innovation in the healthcare diagnostics sector positions it well for future advancements.
Quest Diagnostics presents a moderate to good overall fundamental rating with strengths in return metrics, though it shows weakness in debt levels and valuation multiples.
| Category | Score / 5 | Score Bar |
|---|---|---|
| Discounted Cash Flow (DCF) | 4 | |
| Return on Equity (ROE) | 4 | |
| Return on Assets (ROA) | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
The historical rating showcases consistency in certain aspects but indicates variability in overall performance.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-18 | 3 | 4 | 4 | 5 | 1 | 2 | 2 |
| 2025-06-17 | 3 | 4 | 4 | 5 | 1 | 2 | 2 |
Analysts have set conservative targets reflecting the market's cautious outlook, with a consensus holding steady at a mid-range level.
| High | Low | Median | Consensus |
|---|---|---|---|
| $195 | $180 | $185.5 | $186.5 |
Current analyst sentiment suggests a prevailing neutral stance, with a majority recommending to hold positions.
| Recommendation | Number of Analysts | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 14 | |
| Hold | 17 | |
| Sell | 3 | |
| Strong Sell | 0 |
Quest Diagnostics Incorporated showcases moderate strength in returns and robust innovation, but faces challenges in its debt management and valuation metrics. The stock's analyst sentiment is predominantly neutral, suggesting a cautious approach from the market. While the price goals indicate some potential upside, the risks associated with high debt levels warrant careful consideration. In conclusion, DGX represents a balanced mix of opportunities and challenges, reflective of its stable yet competitive standing in the healthcare diagnostics industry.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.